LYNN KOCIAN: Open Payments
NPI 1386631026 · GRETNA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,785 in 116 payments from 32 companies in 2025. Trend: 2023 $2,124 · 2024 $2,365 · 2025 $1,785
Food & beverage: $1,785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $384 |
| AstraZeneca Pharmaceuticals LP | 8 | $219 |
| Lilly USA, LLC | 14 | $154 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 8 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| SANOFI-AVENTIS U.S. LLC | 3 | $51 |
| Abbott Laboratories | 2 | $48 |
Products named: VRAYLAR, BREZTRI, QULIPTA, REXULTI, HETLIOZ, ZENPEP, KISUNLA, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
